{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:13Z","timestamp":1791338053424,"version":"4.3.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Steinhart-Reed Foundation"},{"DOI":"10.13039\/501100008731","name":"European Leukodystrophy Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003194","name":"New York Stem Cell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Child Neurology Society"},{"DOI":"10.13039\/100011671","name":"G Harold and Leila Y. Mathers Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011671","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pelizaeus-Merzbacher disease (PMD) is an X-linked disorder caused by mutation in the proteolipid protein-1 (PLP1) gene, which encodes the proteolipid protein of myelinating oligodendroglia. PMD exhibits phenotypic variability that reflects its considerable genotypic heterogeneity, but all forms of the disease result in central hypomyelination, associated in most cases with early neurological dysfunction, progressive deterioration, and ultimately death. PMD may present as a connatal, classic and transitional forms, or as the less severe spastic paraplegia type 2 and PLP-null phenotypes. These disorders are most often associated with duplications of the PLP1 gene, but can also be caused by coding and noncoding point mutations as well as full or partial deletion of the gene. A number of genetically-distinct but phenotypically-similar disorders of hypomyelination exist which, like PMD, lack any effective therapy. Yet as relatively pure CNS hypomyelinating disorders, with limited involvement of the PNS and relatively little attendant neuronal pathology, PMD and similar hypomyelinating disorders are attractive therapeutic targets for neural stem cell and glial progenitor cell transplantation, efforts at which are now underway in a number of research centers.<\/jats:p>","DOI":"10.1002\/stem.2530","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T04:16:43Z","timestamp":1479961003000},"page":"311-315","source":"Crossref","is-referenced-by-count":42,"title":["Concise Review: Stem Cell-Based Treatment of Pelizaeus-Merzbacher Disease"],"prefix":"10.1093","volume":"35","author":[{"given":"M. Joana","family":"Osorio","sequence":"first","affiliation":[{"name":"a Center for Basic and Translational Neuroscience, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Rowitch","sequence":"additional","affiliation":[{"name":"b Departments of Pediatrics and Neurosurgery, UCSF School of Medicine and Broad Center for Regenerative Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tesar","sequence":"additional","affiliation":[{"name":"c Department of Genetics and Genome Sciences, Case Western Reserve School of Medicine, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Wernig","sequence":"additional","affiliation":[{"name":"d Institute for Stem Cell Biology and Regenerative Medicine"},{"name":"e Department of Pathology, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Windrem","sequence":"additional","affiliation":[{"name":"f Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Goldman","sequence":"additional","affiliation":[{"name":"a Center for Basic and Translational Neuroscience, University of Copenhagen, Copenhagen, Denmark"},{"name":"f Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"2022010902100458300_stem2530-bib-0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02893591","article-title":"Eine eigenartige famili\u00e4r-heredit\u00e4re Erkrankungsform (Aplasia axialis extracorticalis congenita)","volume":"3","author":"Merzbacher","year":"1910","journal-title":"Zeitschrift F\u00fcr Die Gesamte Neurologie Und Psychiatrie"},{"key":"2022010902100458300_stem2530-bib-0002","first-page":"698","article-title":"Ueber eine eigenth\u00fcmliche Form spastischer L\u00e4hmung mit Cerebralerscheinungen auf heredit\u00e4rer Grundlage","volume-title":"Archiv fur Psychiatrie und Nervenkrankheiten","author":"Pelizaeus","year":"1885"},{"key":"2022010902100458300_stem2530-bib-0003","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.gim.0000223551.95862.c3","article-title":"Quantifying the carrier female phenotype in Pelizaeus-Merzbacher disease","volume":"8","author":"Hurst","year":"2006","journal-title":"Genet Med"},{"key":"2022010902100458300_stem2530-bib-0004","first-page":"461","article-title":"Genetic homogeneity of Pelizaeus-Merzbacher disease: Tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group","volume":"55","author":"Boespflug-Tanguy","year":"1994","journal-title":"Am J Hum Genet"},{"key":"2022010902100458300_stem2530-bib-0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF00290964","article-title":"The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome","volume":"72","author":"Mattei","year":"1986","journal-title":"Hum Genet"},{"key":"2022010902100458300_stem2530-bib-0006","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.56.10.1210","article-title":"The molecular pathogenesis of Pelizaeus-Merzbacher disease","volume":"56","author":"Garbern","year":"1999","journal-title":"Arch Neurol"},{"key":"2022010902100458300_stem2530-bib-0007","article-title":"GeneReviews at GeneTests Medical Genetics Information Resource (database online)","volume-title":"PLP1-related disorders","author":"Hobson","year":"1993\u20132016"},{"key":"2022010902100458300_stem2530-bib-0008","first-page":"867","volume-title":"Myelin Biology and Disorders","author":"Hudson","year":"2004"},{"key":"2022010902100458300_stem2530-bib-0009","first-page":"559","volume-title":"Neurodystrophies and Neurolipidosis","author":"Seitelberger","year":"1996"},{"key":"2022010902100458300_stem2530-bib-0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ana.410360618","article-title":"Pelizaeus-Merzbacher disease presenting as spinal muscular atrophy: Clinical and molecular studies","volume":"36","author":"Kaye","year":"1994","journal-title":"Ann Neurol"},{"key":"2022010902100458300_stem2530-bib-0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00018-006-6182-8","article-title":"Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis","volume":"64","author":"Garbern","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"2022010902100458300_stem2530-bib-0012","first-page":"150","volume-title":"Pelizaeus-Merzbacher Disease","author":"Seitelberger","year":"1970"},{"key":"2022010902100458300_stem2530-bib-0013","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4267\/10608\/2649","article-title":"La maladie de Pelizaeus-Merzbacher et une forme de parapl\u00e9gie spastique li\u00e9e \u00e0 l'X sont toutes deux associ\u00e9es au g\u00e8ne PLP","volume":"10","author":"Saugier-Veber","year":"1994","journal-title":"Med Sci (Paris)"},{"key":"2022010902100458300_stem2530-bib-0014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0896-6273(00)80360-8","article-title":"Proteolipid protein is necessary in peripheral as well as central myelin","author":"Garbern","year":"1997","journal-title":"Neuron"},{"key":"2022010902100458300_stem2530-bib-0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/brain\/awf043","article-title":"Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation","author":"Garbern","year":"2002","journal-title":"Brain"},{"key":"2022010902100458300_stem2530-bib-0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ana.10466","article-title":"Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy","volume":"53","author":"Shy","year":"2003","journal-title":"Ann Neurol"},{"key":"2022010902100458300_stem2530-bib-0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ana.24194","article-title":"Hypomyelinating leukodystrophies: Translational research progress and prospects","volume":"76","author":"Pouwels","year":"2014","journal-title":"Ann Neurol"},{"key":"2022010902100458300_stem2530-bib-0018","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymgme.2015.01.006","article-title":"Case definition and classification of leukodystrophies and leukoencephalopathies","volume":"114","author":"Vanderver","year":"2015","journal-title":"Mol Genet Metab"},{"key":"2022010902100458300_stem2530-bib-0019","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00415-014-7429-1","article-title":"A new mutation in GJC2 associated with subclinical leukodystrophy","volume":"261","author":"Abrams","year":"2014","journal-title":"J Neurol"},{"key":"2022010902100458300_stem2530-bib-0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2013.12.001","article-title":"GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease","volume":"111","author":"Gotoh","year":"2014","journal-title":"Mol Genet Metab"},{"key":"2022010902100458300_stem2530-bib-0021","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awn328","article-title":"Hereditary spastic paraplegia is a novel phenotype for GJA12\/GJC2 mutations","volume":"132","author":"Orthmann-Murphy","year":"2009","journal-title":"Brain"},{"key":"2022010902100458300_stem2530-bib-0022","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/WNL.0000000000000754","article-title":"TUBB4A de novo mutations cause isolated hypomyelination","volume":"83","author":"Pizzino","year":"2014","journal-title":"Neurology"},{"key":"2022010902100458300_stem2530-bib-0023","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1523\/JNEUROSCI.1336-13.2013","article-title":"Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication","volume":"33","author":"Clark","year":"2013","journal-title":"J Neurosci"},{"key":"2022010902100458300_stem2530-bib-0024","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0896-6273(94)90358-1","article-title":"Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene","volume":"13","author":"Kagawa","year":"1994","journal-title":"Neuron"},{"key":"2022010902100458300_stem2530-bib-0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0896-6273(94)90214-3","article-title":"Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage","volume":"12","author":"Readhead","year":"1994","journal-title":"Neuron"},{"key":"2022010902100458300_stem2530-bib-0026","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01217305","article-title":"Rumpshaker mouse: A new X-linked mutation affecting myelination: Evidence for a defect in PLP expression","volume":"19","author":"Griffiths","year":"1990","journal-title":"J Neurocytol"},{"key":"2022010902100458300_stem2530-bib-0027","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/glia.20325","article-title":"Processing of PLP in a model of Pelizaeus-Merzbacher disease\/SPG2 due to the rumpshakermutation","volume":"53","author":"McLaughlin","year":"2006","journal-title":"Glia"},{"key":"2022010902100458300_stem2530-bib-0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0896-6273(01)80046-5","article-title":"Assembly of CNS myelin in the absence of proteolipid protein","volume":"18","author":"Klugmann","year":"1997","journal-title":"Neuron"},{"key":"2022010902100458300_stem2530-bib-0029","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2014.03.007","article-title":"Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes","volume":"2","author":"Numasawa-Kuroiwa","year":"2014","journal-title":"Stem Cell Rep"},{"key":"2022010902100458300_stem2530-bib-0030","doi-asserted-by":"crossref","first-page":"17813","DOI":"10.1073\/pnas.0704975104","article-title":"A common mechanism of PLP\/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease","volume":"104","author":"Dhaunchak","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010902100458300_stem2530-bib-0031","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1523\/JNEUROSCI.2097-11.2011","article-title":"Misalignment of PLP\/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease","volume":"31","author":"Dhaunchak","year":"2011","journal-title":"J Neurosci"},{"key":"2022010902100458300_stem2530-bib-0032","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nn.2273","article-title":"Endoplasmic reticulum stress in disorders of myelinating cells","volume":"12","author":"Lin","year":"2009","journal-title":"Nat Neurosci"},{"key":"2022010902100458300_stem2530-bib-0033","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajhg.2014.03.001","article-title":"Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model","volume":"94","author":"Prukop","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2022010902100458300_stem2530-bib-0034","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.2833","article-title":"Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet","volume":"18","author":"Saher","year":"2012","journal-title":"Nat Med"},{"key":"2022010902100458300_stem2530-bib-0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymgme.2012.02.016","article-title":"Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease","volume":"106","author":"Yu","year":"2012","journal-title":"Mol Genet Metab"},{"key":"2022010902100458300_stem2530-bib-0036","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm974","article-title":"Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain","volume":"10","author":"Windrem","year":"2004","journal-title":"Nat Med"},{"key":"2022010902100458300_stem2530-bib-0037","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.stem.2008.03.020","article-title":"Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse","volume":"2","author":"Windrem","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022010902100458300_stem2530-bib-0038","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","article-title":"Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination","volume":"12","author":"Wang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2022010902100458300_stem2530-bib-0039","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archneurol.2011.46","article-title":"Progenitor cell-based treatment of the pediatric myelin disorders","volume":"68","author":"Goldman","year":"2011","journal-title":"Arch Neurol"},{"key":"2022010902100458300_stem2530-bib-0040","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1093\/hmg\/ddn052","article-title":"Stem cell-based strategies for treating pediatric disorders of myelin","volume":"17","author":"Goldman","year":"2008","journal-title":"Hum Mol Genet"},{"key":"2022010902100458300_stem2530-bib-0041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nec.2006.10.009","article-title":"Glial progenitor-based repair of demyelinating neurological diseases","volume":"18","author":"Keyoung","year":"2007","journal-title":"Neurosurg Clin N Am"},{"key":"2022010902100458300_stem2530-bib-0042","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458507087324","article-title":"Stem cell therapy in multiple sclerosis: Promise and controversy","volume":"14","author":"Duncan","year":"2008","journal-title":"Mult Scler"},{"key":"2022010902100458300_stem2530-bib-0043","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.1218071","article-title":"Glial progenitor cell-based treatment and modeling of neurological disease","volume":"338","author":"Goldman","year":"2012","journal-title":"Science"},{"key":"2022010902100458300_stem2530-bib-0044","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm837","article-title":"Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain","volume":"9","author":"Nunes","year":"2003","journal-title":"Nat Med"},{"key":"2022010902100458300_stem2530-bib-0045","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/brain\/124.11.2147","article-title":"Towards the reconstruction of central nervous system white matter using neural precursor cells","volume":"124","author":"Mitome","year":"2001","journal-title":"Brain"},{"key":"2022010902100458300_stem2530-bib-0046","doi-asserted-by":"crossref","first-page":"155ra136","DOI":"10.1126\/scitranslmed.3004371","article-title":"Human neural stem cells induce functional myelination in mice with severe dysmyelination","volume":"4","author":"Uchida","year":"2012","journal-title":"Sci Transl Med"},{"key":"2022010902100458300_stem2530-bib-0047","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1073\/pnas.96.12.7029","article-title":"Global\u201d cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain","volume":"96","author":"Yandava","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010902100458300_stem2530-bib-0048","doi-asserted-by":"crossref","first-page":"155ra137","DOI":"10.1126\/scitranslmed.3004373","article-title":"Neural stem cell engraftment and myelination in the human brain","volume":"4","author":"Gupta","year":"2012","journal-title":"Sci Transl Med"},{"key":"2022010902100458300_stem2530-bib-0049","doi-asserted-by":"crossref","first-page":"e1451","DOI":"10.1542\/peds.2013-3604","article-title":"Umbilical cord blood transplantation to treat pelizaeus-merzbacher disease in 2 young boys","volume":"134","author":"Wishnew","year":"2014","journal-title":"Pediatrics"},{"key":"2022010902100458300_stem2530-bib-0050","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"2022010902100458300_stem2530-bib-0051","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"2022010902100458300_stem2530-bib-0052","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022010902100458300_stem2530-bib-0053","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/bmt.2014.93","article-title":"Hematopoietic SCT: A useful treatment for late metachromatic leukodystrophy","volume":"49","author":"Solders","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2022010902100458300_stem2530-bib-0054","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1074\/jbc.R113.488247","article-title":"A cut above the rest: Targeted genome editing technologies in human pluripotent stem cells","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"key":"2022010902100458300_stem2530-bib-0055","doi-asserted-by":"crossref","first-page":"1247391","DOI":"10.1126\/science.1247391","article-title":"Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease","volume":"345","author":"Fox","year":"2014","journal-title":"Sci"},{"key":"2022010902100458300_stem2530-bib-0056","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/bies.201200114","article-title":"Genome damage in induced pluripotent stem cells: Assessing the mechanisms and their consequences","volume":"35","author":"Hussein","year":"2013","journal-title":"Bioessays"},{"key":"2022010902100458300_stem2530-bib-0057","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/stem.1011","article-title":"Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells","volume":"30","author":"Ji","year":"2012","journal-title":"Stem Cells"},{"key":"2022010902100458300_stem2530-bib-0058","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.stemcr.2013.11.006","article-title":"Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells","volume":"2","author":"Sugiura","year":"2014","journal-title":"Stem Cell Rep"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.2530","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.2530","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.2530","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/35\/2\/311\/42020236\/stmcls_35_2_311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/35\/2\/311\/42020236\/stmcls_35_2_311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:59:20Z","timestamp":1642561160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/35\/2\/311-315\/6421092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,11,23]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.2530","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2016,11,23]]}}}